* K: Session in Korean
| Time | ROOM 1 (3F) |
ROOM 2 (3F) |
ROOM 3 (2F) |
ROOM 4 (2F) |
ROOM 5 (2F) |
Time |
|---|
* K: Session in Korean
| Time | ROOM 6 (1F) |
ROOM 6-1 (1F) |
ROOM 7 (1F) |
ROOM 8 (1F) |
ROOM 9 (1F) |
Exhibition Hall (1F) |
Time | |
|---|---|---|---|---|---|---|---|---|
| 07:30-08:50 |  TranslationalHepatology 07:30-08:50 |
KASL SIG 3The KASL Autoimmune and Rare Liver Disease Study Group 07:30-08:50 |
Industry Forum 2 Astrazeneca 07:30-08:10 |
Booth & Poster Exhibition 08:00-16:30 |
07:30-08:50 | |||
|---|---|---|---|---|---|---|---|---|
| 08:50-09:10 | Industry Forum 4Daewoong 08:30-09:10 |
Industry Forum 5Gilead 08:30-09:10 |
08:50-09:10 | |||||
| 09:10-10:30 | KASL Symposium 1LC and Portal HTN 09:10-10:30 |
09:10-10:30 | ||||||
| 10:30-10:50 | 10:30-10:50 | |||||||
| 10:50-11:10 | 10:50-11:10 | |||||||
| 11:10-11:40 | 11:10-11:40 | |||||||
| 11:40-12:40 | 11:40-12:40 | |||||||
| 12:40-13:30 | Luncheon Symposium 8 Samil 12:40-13:30 |
Luncheon Symposium 9 Eisai 12:40-13:30 |
12:40-13:30 | |||||
| 13:30-14:50 | Health Insurance and Policy Forum (*K) 13:30-14:50 |
TLW SIGPrecision Oncology 13:30-14:50 |
13:30-14:50 | |||||
| 14:50-15:10 | Coffee Break 14:50-15:10 |
14:50-15:10 | ||||||
| 15:10-16:30 | Free Paper 3 MASLD, Clinical 15:10-16:30 |
Free Paper 4 HBV Basic & ALD 15:10-16:30 |
Free Paper 5 Acute Liver Failure & DILI 15:10-16:30 |
Free Paper 6 HBV 1 15:10-16:30 |
Free Paper 7 Liver Cancer, Basic 15:10-16:30 |
15:10-16:30 | ||
| 16:40-17:40 | Poster Oral Presentation 16:40-17:40 |
16:40-17:40 | ||||||
| 18:00- | Welcome Reception 18:00- |
18:00- | ||||||
07:30-08:50
KASL Special Interest Group 1. The KASL Steatotic Liver Disease Study Group
Challenges to Overcome in the Era of MASLD
Chair: Byoung Kuk Jang (Keimyung Univ.), Su Jong Yu (Seoul National Univ.)
- 07:30-07:50
-
Best Strategies to Assess Advanced Fibrosis in MASLD
Mi Na Kim (Yonsei Univ.)
- 07:50-08:10
-
Use of Anti-Diabetic Drugs in MASLD: Can We Kill Two Birds with One Stone?
Joonyub Lee (The Catholic Univ. of Korea)
- 08:10-08:35
-
Relationship between MASLD and Chronic Hepatitis B: Friends or Foes
Shang-Chin Huang (National Taiwan Univ., Taiwan)
- 08:35-08:50
-
Discussion
Mi Na Kim (Yonsei Univ.), Joonyub Lee (The Catholic Univ. of Korea), Shang-Chin Huang (National Taiwan Univ., Taiwan)
09:10-10:30
KASL-AASLD Joint Symposium 1
Randomized Controlled Trials in Hepatology
Chair: W. Ray Kim (Mayo Clinic, USA), Yoon Jun Kim (Seoul National Univ.)
- 09:10-09:30
-
Practical Tips for Designing and Conducting Successful RCT
Sumeet Asrani (Baylor Univ., USA)
- 09:30-09:50
-
Biases, Challenges, and Innovations in RCT Statistics
Inkyung Jung (Yonsei Univ.)
- 09:50-10:10
-
Successes and Failures in RCT: Insights from AASLD Experiences
Kris V. Kowdley (Washington State Univ., USA)
- 10:10-10:30
-
Successes and Failures in RCT: Insights from KASL Experiences
Young-Suk Lim (Univ. of Ulsan)
11:10-11:40
State-of-the-Art Lecture
Chair: Masao Omata (The Univ. of Tokyo, Japan)
- 11:10-11:40
-
HBV with Co-Existing Liver Diseases: The Interactions between Viral Hepatitis C, MAFLD, and HBV
Chun-Jen Liu (National Taiwan Univ., Taiwan)
11:40-12:40
Plenary Presentation 1
Chair: Sung Su Yun (Yeungnam Univ.), Mi-Sook Kim (Korea Cancer Center Hospital), Yong-Han Paik (Sungkyunkwan Univ.)
- 11:40-11:55
-
CXCR4+ CD8+ T Cells in Alcoholic Liver Disease: Enhanced Cytotoxicity and Associations with Liver Function Markers
Pil Soo Sung (The Catholic Univ. of Korea)
- 11:55-12:10
-
Adjuvant Cytokine-Induced Killer Cell Immunotherapy in Hepatocellular Carcinoma: 9-Year Extended Follow-Up of a Randomized Controlled Trial and Post-Treatment Immune Cell Profiling
Hyunjae Shin (Seoul National Univ.)
- 12:10-12:25
-
Surgical Quality Assessment with Artificial Intelligence-Based Video Analysis for Laparoscopic Donor Right Hemihepatectomy: Usefulness of Round Ligament Fixation in Hilar Structure Dissection
Dai Hoon Han (Yonsei Univ.)
- 12:25-12:40
-
Performance of Expanded Criteria for Liver Transplantation in Patients with Hepatocellular Carcinoma: A Network Meta-Analysis
Yeongseok Hwang (Univ. of Ulsan)
13:30-14:50
KASL Symposium 2
The Immunological Horizon Towards Curing Viral Hepatitis and Beyond
Chair: Chun-Jen Liu (National Taiwan Univ., Taiwan), Sang Hoon Ahn (Yonsei Univ.)
- 13:30-13:50
-
Pipelines for Curing Hepatitis B Using Immunological Targets: Successes and Failures
Won-Mook Choi (Univ. of Ulsan)
- 13:50-14:10
-
Targeting Innate Immunity as a Promising Approaches for Curing Hepatitis B
Loey Lung-Yi Mak (The Univ. of Hong Kong, Hong Kong)
- 14:10-14:30
-
Targeting Adaptive Immunity as a Promising Approaches for Curing Hepatitis B
Markus Cornberg (Hannover Medical School, Germany)
- 14:30-14:50
-
Development of a Novel Immune Modulator SA-5 as a Therapeutic Option for Chronic Hepatitis B
Tatsuya Kanto (Japan Institute for Health Security, Japan)
15:10-16:30
KASL-KAHBPS-KLCA-KLTS Joint Symposium
Multidisciplinary Practices to Prevent Hepatocellular Carcinoma Occurrence and Recurrence
Chair: Tae Hun Kim (Ewha Womans Univ.), Dong-Hwan Jung (Univ. of Ulsan)
- 15:10-15:30
-
Etiology-Based Primary Prevention Strategies for Hepatocellular Carcinoma
Jeong Han Kim (Konkuk Univ.)
- 15:30-15:50
-
Post-Resection Monitoring and Predictors for Hepatocellular Carcinoma Recurrence
Min-Su Park (Kyung Hee Univ.)
- 15:50-16:10
-
Diagnosis and Multidisciplinary Management of Recurrent Hepatocellular Carcinoma after Hepatectomy
Hye Won Lee (Yonsei Univ.)
- 16:10-16:30
-
Criteria and Workups for Liver Transplant Eligibility in Recipients Focus on Hepatocellular Carcinoma Patients
Seok-Hwan Kim (Chungnam National Univ.)
07:30-08:50
KLCA Symposium 1
Evolving Epidemiology and Advancing Surveillance of Hepatocellular Carcinoma
Chair: Joong-Won Park (Myoungji Hospital, Hanyang Univ.), Jin Wook Chung (Seoul National Univ.)
- 07:30-07:50
-
Trends from the Nationwide Cancer Registry
Han Ah Lee (Chung-Ang Univ.)
- 07:50-08:10
-
Future Trends in HCC Epidemiology in Korea
Young Eun Chon (CHA Univ.)
- 08:10-08:30
-
Imaging and Beyond: Expanding HCC Surveillance Modalities
Hyuk Soo Eun (Chungnam National Univ.)
- 08:30-08:50
-
The Future of Imaging-Based HCC Surveillance: Personalized Approaches and Artificial Intelligence
Hyo Jung Park (Univ. of Ulsan)
08:50-09:10
Liver Biopsy in Hepatocellular Carcinoma (*K)
Chair: Kyung Sik Kim (Yonsei Univ.)
- 08:50-09:10
-
The Role of Liver Biopsy in Hepatocellular Carcinoma Management: A KLCA Perspective
Hae Lim Lee (The Catholic Univ. of Korea)
09:10-10:30
KLCA Symposium 2
Advancing Biomarker Discovery and Translational Insights in Liver Cancer
Chair: Seung Kew Yoon (The Catholic Univ. of Korea), Hee Chul Yu (Jeonbuk National Univ.)
- 09:10-09:30
-
Liquid vs. Tissue Biopsy to Support Treatment Decisions in HCC
Soung Won Jeong (Soonchunhyang Univ.)
- 09:30-09:50
-
Artificial Intelligence-Based Pathology as a Biomarker of Sensitivity to Immunotherapy
Sung Hak Lee (The Catholic Univ. of Korea)
- 09:50-10:10
-
Strategies to Effectively Drive the Cancer-Immunity Cycle: Roles of Each Therapeutic Modality in Hepatocellular Carcinoma
Hideki Iwamoto (Kurume Univ., Japan)
- 10:10-10:30
-
Mechanisms of Metastasis Revealed through Single-Cell Spatial Transcriptome Analysis in Patients with Liver Metastatic Colorectal Cancer
Jungmin Choi (Korea Univ.)
13:30-14:50
KLCA-JLCA Joint Symposium
Optimizing Bridging Gaps in Pre- and Post-Liver Transplantation Management for Hepatocellular Carcinoma
Chair: June Sung Lee (Inje Univ.), Etsuro Hatano (Kyoto Univ., Japan)
- 13:30-13:50
-
Pre-Transplant HCC Control: Surgical Resection and Bridging Strategies
Jongman Kim (Sungkyunkwan Univ.)
- 13:50-14:10
-
Innovative Bridging Therapies for HCC: From Transarterial Chemoembolization to Immune Checkpoint Inhibitors
Tomoharu Yamada (The Univ. of Tokyo, Japan)
- 14:10-14:30
-
Post-Transplant HCC Recurrence: Predictors, Surveillance, and Novel Interventions
Soon Sun Kim (Ajou Univ.)
- 14:30-14:50
-
Immunosuppression and Immunotherapy in Post-Liver Transplant HCC: Striking the Right Balance
Tomoharu Yoshizumi (Kyushu Univ., Japan)
07:30-08:50
KAHBPS Symposium 1
Assessment and Management of Uncommon Considerations in Liver Surgery
Chair: Chinburen Jigjidsuren (National Cancer Center, Mongolia), Young Chul Yoon (The Catholic Univ. of Korea)
- 07:30-07:50
-
High-Grade Morbid Obesity
Unenbat Gurbadam (National Cancer Center, Mongolia)
- 07:50-08:10
-
Severe Cardiovascular Disease
Haeil Jung (Soonchunhyang Univ.)
- 08:10-08:30
-
Elderly Patients over 75 Years
Etsuro Hatano (Kyoto Univ., Japan)
- 08:30-08:50
-
End-Stage Renal Disease
Chan Woo Cho (Yeungnam Univ.)
09:10-10:30
KAHBPS Symposium 2
Laparoscopic Liver Resection vs. Robotic Liver Resection
Chair: Poowanai Sarkhampee (Sunpasitthiprasong Hospital, Thailand), Sang Jin Kim (Korea Univ.)
- 09:10-09:30
-
Technical Differences in Surgical Approaches
Dai Hoon Han (Yonsei Univ.)
- 09:30-09:50
-
Challenges and Learning Curve for Beginners
Su Young Hong (Seoul National Univ.)
- 09:50-10:10
-
Clinical Outcomes and Complications: Laparoscopic vs. Robotic Liver Resection
Kwan Woo Kim (Dong-A Univ.)
- 10:10-10:30
-
Open Liver Resection as a Good Surgical Approach: Indications and Outcomes
Kwangho Yang (Pusan National Univ.)
09:10-10:30
Hepatology Associates 1 (*K)
Updates in Clinical Hepatology
Chair: Jaeseok Hwang (Keimyung Univ.), Hee Bok Chae (Chungbuk National Univ.)
- 09:10-09:30
-
Percutaneous Liver Biopsy: When to Decide to Perform and How to Minimize Risk
Hyeon Ji Jang (Univ. of Ulsan)
- 09:30-09:50
-
Management of Hospitalized Patients with Alcohol Withdrawal Syndrome
Jae Hyun Yoon (Chonnam National Univ.)
- 09:50-10:10
-
Inpatient Care for Gastrointestinal Bleeding in Patients with Liver Cirrhosis
Heechul Nam (The Catholic Univ. of Korea)
- 10:10-10:30
-
Precipitating Factors and Management of Hepatic Encephalopathy
Jae Seung Lee (Yonsei Univ.)
11:20-12:40
KLTS Coordinator Session (*K)
Multidisciplinary Approach to Liver Transplantation for Alcohol-Associated Liver Disease
Chair: Seung Heui Hong (Samsung Medical Center), Hae Won Lee (Seoul National Univ.)
- 11:20-11:40
-
Alcohol Dependence and Liver Transplantation: The Importance of Mental Health Care
Kye-Seong Lee (Incheon Chamsarang Hospital)
- 11:40-12:00
-
Liver Transplantation for Alcohol-Associated Liver Disease: Surgical Perspective and Prognosis
Hae Won Lee (Seoul National Univ.)
- 12:00-12:20
-
Coordination of the Liver Transplant Process and Patient Management for Alcoholic Liver Disease: Evolving Roles of Transplant Coordinators in Korea
Sunyoung Son (Gangnam Severance Hospital)
- 12:20-12:40
-
Social Support and Rehabilitation for Liver Transplant Patients with Alcohol-Associated Liver Disease
Eunseon Suh (Hwaseong Community Addiction Management Center)
13:30-14:50
KAHBPS Symposium 3
Recent Updates in Cholangiocarcinoma
Chair: In Seok Choi (Konyang Univ.), Jin-Young Jang (Seoul National Univ.)
- 13:30-13:50
-
Minimal Invasive Surgery for Intrahepatic Cholangiocarcinoma
Kyeong Deok Kim (Inha Univ.)
- 13:50-14:10
-
Extent of Lymph Node Dissection in Intrahepatic Cholangiocarcinoma
Poowanai Sarkhampee (Sunpasitthiprasong Hospital, Thailand)
- 14:10-14:30
-
Surgical Approaches for Hilar Cholangiocarcinoma
Sang Hwa Song (Chonnam National Univ.)
- 14:30-14:50
-
Role of Liver Transplantation in the Treatment of Intrahepatic Cholangiocarcinoma
Amit Singal (UT Southwestern Medical Center, USA)
07:30-08:50
KASL Special Interest Group 3. The KASL Autoimmune and Rare Liver Disease Study Group
Exploring Autoimmune and Rare Liver Diseases
Chair: Kyung-Ah Kim (Inje Univ.), Atsushi Tanaka (Teikyo Univ., Japan)
- 07:30-07:55
-
Challenges in the Diagnosis and Treatment of Autoimmune Hepatitis
Soon Kyu Lee (The Catholic Univ. of Korea)
- 07:55-08:25
-
Current Status and Research Trends of Autoimmune Liver Diseases in Japan
Atsushi Tanaka (Teikyo Univ., Japan)
- 08:25-08:50
-
Updates in Diagnosis and Management of Rare Vascular Liver Diseases
Yu Rim Lee (Kyungpook National Univ.)
09:10-10:30
KASL Symposium 1
Innovative Strategies in Cirrhosis Care
Chair: Barjesh Chander Sharma (Govind Ballabh Pant Hospital, India), Jae Young Jang (Soonchunhyang Univ.)
- 09:10-09:30
-
Primary Hemostasis in Cirrhosis: A Modern Perspective on Coagulopathy
Manoj Kumar Sharma (Institute of Liver and Biliary Sciences, India)
- 09:30-09:50
-
Metabolomic Biomarkers for Risk Stratification and Prognosis Prediction in Cirrhotic Patients
Eun Ju Cho (Seoul National Univ.)
- 09:50-10:10
-
Recompensation in Cirrhosis: Mechanisms, Predictors, and Therapeutic Strategies
Byeong Geun Song (Sungkyunkwan Univ.)
- 10:10-10:30
-
Treatment of Portal Hypertension in Patients with Hepatocellular Carcinoma in the Era of Baveno VII
Dominique Damais-Thabut (Sorbonne Univ., France)
13:30-14:50
TLW Special Interest Group
Integrating Multi-Omics for Precision Oncology
Chair: Chien-Hung Chen (National Taiwan Univ., Taiwan), Jaeyoun Cheong (Ajou Univ.)
- 13:30-13:50
-
Integration of Clinical, Computational, and Genomic Resources for Early HCC Detection
Augusto Villanueva (NYU Langone, USA)
- 13:50-14:10
-
Molecular Insights into HCC Recurrence from Minimal Residual Disease after Therapy
Renumathy Dhanasekaran (Stanford Univ., USA)
- 14:10-14:30
-
Immune Microenvironment and Therapeutic Discovery in HCC Using Single-Cell Omics Analysis
Valerie Chew (Duke-NUS Medical School, Singapore)
- 14:30-14:50
-
Genomic Characteristics of RB1-Deficient HCC and Its Therapeutic Candidates
Ju Hyun Shim (Univ. of Ulsan)
07:30-08:50
KASL Special Interest Group 2. The KASL Abdominal Ultrasound Study Group
Recent Progress in Clinical Application of Ultrasound
Chair: Soon Koo Baik (Yonsei Univ. Wonju), Sang Gyune Kim (Soonchunhyang Univ.)
- 07:30-07:50
-
Comparison of Liver Fibrosis Assessment Using VCTE versus SWE
Moon Hyung Lee (Kyung Hee Univ.)
- 07:50-08:10
-
The Role of Ultrasound in the Diagnosis and Assessment of MASLD
Heejoon Jang (Seoul National Univ.)
- 08:10-08:30
-
Outcome Prediction Using Ultrasound in Chronic Liver Diseases
Jun Sik Yoon (Inje Univ.)
- 08:30-08:50
-
Discussion
07:20-08:30
Industry Forum 1 [Roche]
Moderator: Yi-Hsiang Huang (National Yang Ming Chiao Tung Univ., Taiwan)
- 07:20-07:30
-
Tune-In Session
- 07:30-07:35
-
Opening Remark
- 07:35-07:50
-
Case 1. Enhancing Survival with IO + Anti-VEGF
The Role of Combination Therapy in Achieving an Earlier Impact on Patient OutcomesHideki Iwamoto (Kurume Univ., Japan)
- 07:50-08:00
-
Polling and Discussion
- 08:00-08:15
-
Case 2. Preserving Liver Function with Early-Stage Treatment
The Importance of Timely Intervention and MDT Collaboration, with Insights from TACE-R and TACE-U CasesJacob George (The Univ. of Sydney, Australia)
- 08:15-08:25
-
Polling and Discussion
- 08:25-08:30
-
Closing Remark
08:30-09:10
Industry Forum 3 [Yuhan]
Moderator: Young-Sun Lee (Korea Univ.)
- 08:30-09:10
-
Development Progress of Oral GLP-1 Receptor Agonists for Obesity Treatment
Se-Woong Oh (Yuhan Corp.)
07:30-08:10
Industry Forum 2 [AstraZeneca]
Chair: Yoon Jun Kim (Seoul National Univ.)
- 07:30-07:50
-
IO-Based Combinations in Advanced Hepatocellular Carcinoma: Real-World STRIDE Experience and Clinical Impact on Unmet Needs
Amit Singal (UT Southwestern Medical Center, USA)
- 07:50-08:10
-
Discussion
08:30-09:10
Industry Forum 4 [Daewoong]
Moderator: Seung Kak Shin (Gachon Univ.)
- 08:30-09:10
-
Top-Line Results of Phase 4 Clinical Trial for Vemliver (Tenofovir Alafenamide Hemitartrate) Announced
Yeowool Kang (Dong-A Univ.)
08:30-09:10
Industry Forum 5 [Gilead]
Moderator: Eun Sun Jang (Seoul National Univ.)
- 08:30-09:10
-
Tenofovir: Early Treatment Marks the Beginning of a Cure for Chronic Hepatitis B
Jeong Heo (Pusan National Univ.)
09:10-10:30
Hepatology Associates 1 (*K)
Updates in Clinical Hepatology
Chair: Jaeseok Hwang (Keimyung Univ.), Hee Bok Chae (Chungbuk National Univ.)
- 09:10-09:30
-
Percutaneous Liver Biopsy: When to Decide to Perform and How to Minimize Risk
Hyeon Ji Jang (Univ. of Ulsan)
- 09:30-09:50
-
Management of Hospitalized Patients with Alcohol Withdrawal Syndrome
Jae Hyun Yoon (Chonnam National Univ.)
- 09:50-10:10
-
Inpatient Care for Gastrointestinal Bleeding in Patients with Liver Cirrhosis
Heechul Nam (The Catholic Univ. of Korea)
- 10:10-10:30
-
Precipitating Factors and Management of Hepatic Encephalopathy
Jae Seung Lee (Yonsei Univ.)
13:30-14:50
Data Science Camp 1
Statistics in Hepatology
Chair: Jin-Wook Kim (Seoul National Univ.), Chang Wook Kim (The Catholic Univ. of Korea)
- 13:30-14:10
-
Advanced Survival Analysis
Woojoo Lee (Seoul National Univ.)
- 14:10-14:50
-
Development and Evaluation of Clinical Prediction Models
Sehee Kim (Univ. of Ulsan)
15:10-16:30
Hepatology Associates 2 (*K)
Essential Elements for a Successful Clinical Trial
Chair: Young Seok Kim (Soonchunhyang Univ.), Byung-Cheol Song (Jeju National Univ.)
- 15:10-15:30
-
Differences between Sponsor-Initiated Trials and Investigator-Initiated Trials
Minjong Lee (Ewha Womans Univ.)
- 15:30-15:50
-
Human Subjects Protection and Data Review Board
Seungwon Jeung (Korea Health Information Service)
- 15:50-16:10
-
Collection and Management of Patient-Derived Samples in Clinical Trials
Dae Won Jun (Hanyang Univ.)
- 16:10-16:30
-
Keywords for Investigator-Initiated Trials (IIT): What Academia Needs to Know
Elisabet Kim (Asan Medical Center)
07:30-08:50
Translational Hepatology
Promising Cutting-Edge Translational Liver Study
Chair: Youngmi Jung (Pusan National Univ.), Ja Hyun Koo (Seoul National Univ.)
- 07:30-07:50
-
Tracing Cellular Dynamics during Intestinal Tumorigenesis and Metastasis
Min Kyu Yum (KAIST)
- 07:50-08:10
-
Histone Lactylation: A Novel Epigenetic Mark in Liver Fibrosis
Hyunsoo Rho (Ewha Womans Univ.)
- 08:10-08:30
-
Casp2: The New Hepatic Lipid Regulator
Ju Youn Kim (Hanyang Univ.)
- 08:30-08:50
-
Identification of Novel Targets for the Treatment of MASLD
Keon Wook Kang (Seoul National Univ.)
13:30-14:50
Health Insurance and Policy Forum (*K)
Chair: In Hee Kim (Jeonbuk National Univ.), Hyun Woong Lee (Yonsei Univ.)
Panelist: Yunsuk Kim (Korea Disease Control and Prevention Agency)
- 13:30-13:50
-
Current Status and Unmet Need of Reimbursement of Systemic Chemotherapy for HCC
Eileen L. Yoon (Hanyang Univ.)
- 13:50-14:10
-
Procedural Standards for Health Insurance Coverage and Criteria for Oncology Drug Reimbursement
Mi Young Kang (Health Insurance Review and Assessment Service)
- 14:10-14:30
-
Introduction of National Hepatitis C Screening and Post-Screening Management Plan
Young Joon Park (Korea Disease Control and Prevention Agency)
- 14:30-14:50
-
Disease Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease and Management of High-Risk Groups in Korea
Won-Ho Kim (Korea National Institute of Health)
